<DOC>
	<DOCNO>NCT00670267</DOCNO>
	<brief_summary>The purpose study confirm previous observation asthmatic chronic nadolol treatment reduces asthmatic airway hyper-responsiveness .</brief_summary>
	<brief_title>Oral Nadolol Treatment Adults With Mild Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Nadolol</mesh_term>
	<criteria>Prebronchodilator FEV1 80 % great predict value . PC20 FEV1 ≤4 mg/ml methacholine challenge test . Blood Pressure ≥ 100/65mm Hg . Pulse rate ≥ 60 beats/min . No significant health issue . Nonsmoker Xsmoker &lt; 10 pack/year . History upper/lower respiratory tract infection asthma exacerbation within 6 week first baseline visit . Currently diagnose chronic obstructive pulmonary disease ( COPD ) . Used oral inhaled corticosteroid within 4 week first baseline visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>hyperresponsiveness</keyword>
</DOC>